According to a recent LinkedIn post from Osmind, the company is promoting monthly SPRAVATO office hours for clinicians and practice teams, with the next session scheduled for May 5 at 9 a.m. PT / 12 p.m. ET. The session is positioned as a forum for guidance on lowering SPRAVATO drug costs, onboarding, setup, and practice management, including live Q&A with experts and peers.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The post suggests Osmind is deepening its engagement with psychiatric practices that use SPRAVATO by offering operational and reimbursement support. For investors, this type of educational programming may help strengthen customer relationships, increase platform stickiness within the Psychiatry Collective community, and potentially drive incremental adoption of Osmind’s practice management solutions in the behavioral health segment.